ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.07
-0.32 (-1.17%)
Feb 21, 2025, 4:00 PM EST - Market closed
ArriVent BioPharma Employees
ArriVent BioPharma had 40 employees as of December 31, 2023.
Employees
40
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,026,200
Market Cap
912.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
AVBP News
- 4 weeks ago - ArriVent BioPharma Enters Exclusive License with Lepu Biopharma for MRG007, an Antibody Drug Conjugate for the treatment of Gastrointestinal Cancers - GlobeNewsWire
- 5 months ago - ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer - GlobeNewsWire
- 6 months ago - Aarvik Therapeutics Announces Option Exercise by Collaboration Partner ArriVent BioPharma - Business Wire
- 6 months ago - ArriVent BioPharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 6 months ago - ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer - GlobeNewsWire
- 9 months ago - ArriVent Announces a Multi-Target ADC Collaboration with Alphamab - GlobeNewsWire
- 10 months ago - ArriVent Appoints John Hohneker, M.D., to its Board of Directors - GlobeNewsWire
- 10 months ago - ArriVent BioPharma Reports First Quarter 2024 Financial Results - GlobeNewsWire